Cytokine networks in the pancreatic ductal adenocarcinoma microenvironment

Pancreatic ductal adenocarcinoma (PDAC) is associated with a particularly poor prognosis, as reflected by the five-year relative survival rate of only 13% for pancreatic cancer in the United States (3% for distant-stage disease), which contrasts sharply with the higher survival rates observed in breast cancer (91%), prostate cancer (97%), and colon cancer (63%). Despite advances in therapies, PDAC outcomes remain poor due to its complex tumor microenvironment (TME), characterized by immune-stromal interactions that drive progression and immunosuppression. Key cytokines like interleukins promote fibrosis and tumor growth, while growth factors enhance invasiveness and therapy resistance. Interferons, Tumor necrosis factors, and Colony-stimulating factors modulate immune responses, and chemokines orchestrate immune cell trafficking and metastasis. These components collectively create a fibrotic, immunosuppressive niche that hinders treatment efficacy. Emerging therapeutic strategies aim to disrupt TME-related pathways, such as cytokine/chemokine inhibition, stromal reprogramming, and immune checkpoint modulation. Combining targeted TME therapies with chemotherapy or immunotherapy shows promise in overcoming resistance. This review explores the interplay of cytokines, immune dynamics, and stromal signaling in PDAC, highlighting novel therapeutic approaches to improve clinical outcomes by reshaping the TME.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-18
DOI
https://doi.org/10.3389/fmed.2026.1994644
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cytokine networks in the pancreatic ductal adenocarcinoma microenvironment

Fengxiang Lou, Yubo Chi, Huan Liu
3 links
Frontiers in Medicine
Pancreatic and Hepatic Oncology Research
article

Cytokine networks in the pancreatic ductal adenocarcinoma microenvironment

Fengxiang Lou, Yubo Chi, Huan Liu
article en

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is associated with a particularly poor prognosis, as reflected by the five-year relative survival rate of only 13% for pancreatic cancer in the United States (3% for distant-stage disease), which contrasts sharply with the higher survival rates observed in breast cancer (91%), prostate cancer (97%), and colon cancer (63%). Despite advances in therapies, PDAC outcomes remain poor due to its complex tumor microenvironment (TME), characterized by immune-stromal interactions that drive progression and immunosuppression. Key cytokines like interleukins promote fibrosis and tumor growth, while growth factors enhance invasiveness and therapy resistance. Interferons, Tumor necrosis factors, and Colony-stimulating factors modulate immune responses, and chemokines orchestrate immune cell trafficking and metastasis. These components collectively create a fibrotic, immunosuppressive niche that hinders treatment efficacy. Emerging therapeutic strategies aim to disrupt TME-related pathways, such as cytokine/chemokine inhibition, stromal reprogramming, and immune checkpoint modulation. Combining targeted TME therapies with chemotherapy or immunotherapy shows promise in overcoming resistance. This review explores the interplay of cytokines, immune dynamics, and stromal signaling in PDAC, highlighting novel therapeutic approaches to improve clinical outcomes by reshaping the TME.

Frontiers in MedicineVol. 13
Jilin University (CN), First Hospital of Jilin University (CN)
Good health and well-being
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon